| [1] |
Tkalcevic'VI,Bosnjak B,Pasalic'I,et al.The anti-inflammatory activity of clarithromycin inhibits TNFalpha production and prolongs survival following lipopolysaccharide administration in mice[J]. Int J Antimicrob Agents, 2008, 32(2): 195-196.
|
| [2] |
Grau S, Antonio JM, Ribes E, et al. Impact of rifampicin addition to clarithromycin in legionella pneumophila pneumonia[J]. Int J Antimicrob Agents,2006,28(3):249-252.
|
| [3] |
Tsuda T, Ishikawa C,Konishi H,et al. Effect of 14-membered-ring macrolides on production of interleukin-8 mediated by protease-activated receptor 2 in human keratinocytes. Antimicrob Agents Chemother,2008,52(4):1538-1541.
|
| [4] |
Yatsunami J, Hayashi S. Fourteen-membered ring macrolides as anti-angiogenic compounds[J]. Anticancer Res, 2001,21(6B):4253-4258.
|
| [5] |
Yatsunami J, Fukuno Y, Nagata M, et al. Antiangiogenic and antitumor effects of 14-membered ring macrolides on mouse B16 melanoma cells[J]. Clin Exp Metastasis,1999,17(4):361-367.
|
| [6] |
Yatsunami J, Turuta N, Wakamatsu K, et al.Clarithromycin is a potent inhibitor of tumor-induced angiogenesis[J]. Res Exp Med (Berl),1997,197(4):189-197.
|
| [7] |
Qiao AM, Ikejima T, Tashiro S, et al. Involvement of mitochondria and caspase pathways in N-demethyl-clarithromycininduced apoptosis in human cervical cancer HeLa cell[J]. Acta Pharmacol Sin,2006,27(12):1622-1629.
|
| [8] |
The BIG 1-98.Collaborative Group. Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer[J]. N Engl J Med,2009,361(20):766-776.
|
| [9] |
Jordan VC. Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer[J]. Br J Pharmacol,2006,147 (Suppl 1): S269-S276.
|
| [10] |
Jordan VC. Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer[J]. Br J Pharmacol,1993,110 (2):507-517.
|
| [11] |
Desta Z, WardBA, Soukhova NV, et al. Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6[J]. J Pharmacol Exp Ther,2004,310 (3):1062-1075.
|
| [12] |
Wang DY, Fulthorpe R, Liss SN,et al. Identification of estrogen-responsive genes by complementary deoxyribonucleic acid microarray and characterization of a novel early estrogen-induced gene: EEIG1[J]. Mol Endocrinol,2004,18 (2):402-411.
|
| [13] |
Shang Y, Hu X, DiRenzo J, et al. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription[J].Cell,2000,103 (6):843-852.
|
| [14] |
Massarweh S,Osborne CK, Creighton CJ,et al. Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function[J]. Cancer Res,2008,68 (3):826-833.
|
| [15] |
Hurtado A, Holmes KA, Geistlinger TR,et al. Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen[J]. Nature,2008,456 (7222):663-666.
|
| [16] |
Osborne CK, Bardou V, Hopp TA,et al. Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer[J]. J Natl Cancer Inst,2003,95 (5):353-361.
|
| [17] |
Chen J, Thompson LU. Lignans and tamoxifen, alone or in combination, reduce human breast cancer cell adhesion,invasion and migration in vitro[J]. Breast Cancer Res Treat,2003,80(2):163-170.
|
| [18] |
Loo WT, Sasano H, Chow LW. Evaluation of therapeutic efficacy of capecitabine on human breast carcinoma tissues and cell lines in vitro[J]. Biomed Pharmacother,2007,61(9):553-537.
|
| [19] |
Liu Q, Loo WT, Sze SC,et al. Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation of NFkappaB, cyclinD and MMP-1 transcription[J]. Phytomedicine, 2009, 16(10):916-922.
|
| [20] |
Loo WT, Chow LW, Suzuki T,et al. Expression of thymidine phosphorylase and dihydropyrimidine dehydrogenase in human breast carcinoma cells and tissues[J]. Anticancer Res,2009,29(7):2525-2530.
|
| [21] |
Lau GI, Loo WT, Chow LW. Neoadjuvant chemotherapy for breast cancer determined by chemosensitivity assay achieves better tumor response[J]. Biomed Pharmacother,2007,61(9):562-565.
|
| [22] |
Lasfargues EY, Coutinho WG, Redfield ES. Isolation of two human tumor epithelial cell lines from solid breast carcinomas[J]. J Natl Cancer Inst,1978,61(4):967-978.
|
| [23] |
Shinkai M, Tamaoki J,Kobayashi H,et al.Clarithromycin delays progression of bronchial epithelial cells from G1 phase to S phase and delays cell growth via extracellular signal-regulated protein kinase suppression[J]. Antimicrob Agents Chemother,2006,50(5):1738-1744.
|
| [24] |
Goetz MP, Kamal A, Ames MM. Tamoxifen pharmacogenomics: the role of CYP2D6 as a predictor of drug response[J].Clin Pharmacol Ther,2008,83(1):160-166.
|
| [25] |
Chen J, Power KA, Mann J, et al. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen[J]. Exp Biol Med (Maywood), 2007, 232(8):1071-1080.
|
| [26] |
Brodie A, Lu Q, Nakamura J. Aromatase in the normal breast and breast cancer[J]. J Steroid Biochem Mol Biol,1997,61(3-6):281-286.
|